Loraz and Apriso drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Apriso (mesalamine). Common drug interactions include gastric ulcer among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Apriso. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Apriso?

Apriso has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 3,439 Apriso users. Check the latest studies of Apriso.



On Jul, 13, 2026

55 people who take Loraz and Apriso together, and have interactions are studied.

Loraz and Apriso drug interactions.

What are the common drug interactions of Loraz and Apriso, by gender? *:

female:

  1. Gastric ulcer (stomach ulcer)
  2. Gingival pain (gum pain)
  3. Haematocrit decreased
  4. Haemoglobin decreased
  5. Head injury
  6. Hyperhidrosis (abnormally increased sweating)
  7. Injection site bruising
  8. Joint injury
  9. Loss of consciousness
  10. Malaise (a feeling of general discomfort or uneasiness)

male:

  1. Pain
  2. Emotional distress
  3. Blood calcium decreased
  4. Chronic kidney disease
  5. Decreased activity
  6. Foot fracture
  7. Fracture
  8. Grip strength decreased
  9. Hand fracture
  10. Multiple fractures

What are the common drug interactions of Loraz and Apriso, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Biliary colic
  3. Cholecystitis acute (rapid infection of gallbladder)
  4. Diarrhoea
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Nausea (feeling of having an urge to vomit)
  7. Pancreatitis (inflammation of pancreas)
  8. Injection site anaesthesia
  9. Injection site haemorrhage (bleeding from injection site)
  10. Injection site pain

40-49:

  1. Abdominal pain
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Gastric ulcer (stomach ulcer)
  6. Injection site pain
  7. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  8. Nausea (feeling of having an urge to vomit)
  9. Vomiting
  10. Chronic kidney disease

50-59:

  1. Pain
  2. Emotional distress
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Renal failure (kidney dysfunction)
  5. Chronic kidney disease
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Blood calcium decreased
  8. Decreased activity
  9. Foot fracture
  10. Fracture

60+:

  1. Diarrhoea
  2. Bruxism (habitual grinding of the teeth, typically during sleep)
  3. Retinal injury (injury to retina)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Headache (pain in head)
  6. Myalgia (muscle pain)
  7. Paranasal sinus discomfort
  8. Rhinorrhoea (watery mucus discharge from the nose)
  9. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
  10. Age-related macular degeneration

What are the existing conditions these people have? *

  1. Depression: 23 people, 41.82%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 19 people, 34.55%
  3. Pain: 17 people, 30.91%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 21.82%
  5. High Blood Cholesterol: 12 people, 21.82%
  6. Diarrhea: 12 people, 21.82%
  7. Insomnia (sleeplessness): 12 people, 21.82%
  8. High Blood Pressure: 11 people, 20.00%
  9. Asthma: 10 people, 18.18%
  10. Sleep Disorder: 10 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Apriso?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Apriso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Apriso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apriso and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and mesalamine (the active ingredients of Loraz and Apriso, respectively), and Loraz and Apriso (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: